Risk of in-hospital falls among medications commonly used for insomnia in hospitalized patients

  • Shoshana J Herzig
    Division of General Medicine, Department of Medicine, Beth Israel Deaconess Medical Center , Boston, MA , USA
  • Michael B Rothberg
    Center for Value-Based Care Research, Medicine Institute, Cleveland Clinic , Cleveland, OH , USA
  • Caitlyn R Moss
    Division of General Medicine, Department of Medicine, Beth Israel Deaconess Medical Center , Boston, MA , USA
  • Geeda Maddaleni
    Division of General Medicine, Department of Medicine, Beth Israel Deaconess Medical Center , Boston, MA , USA
  • Suzanne M Bertisch
    Harvard Medical School , Boston, MA , USA
  • Jenna Wong
    Harvard Medical School , Boston, MA , USA
  • Wenxiao Zhou
    Division of General Medicine, Department of Medicine, Beth Israel Deaconess Medical Center , Boston, MA , USA
  • Long Ngo
    Division of General Medicine, Department of Medicine, Beth Israel Deaconess Medical Center , Boston, MA , USA
  • Timothy S Anderson
    Division of General Medicine, Department of Medicine, Beth Israel Deaconess Medical Center , Boston, MA , USA
  • Jerry H Gurwitz
    Meyers Primary Care Institute, A Joint Endeavor of University of Massachusetts Medical School, Reliant Medical Group, and Fallon Community Health Plan , Worcester, MA , USA
  • Edward R Marcantonio
    Division of General Medicine, Department of Medicine, Beth Israel Deaconess Medical Center , Boston, MA , USA

この論文をさがす

説明

<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Study Objectives</jats:title> <jats:p>To investigate the risk of in-hospital falls among patients receiving medications commonly used for insomnia in the hospital setting.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>Retrospective cohort study of all adult hospitalizations to a large academic medical center from January, 2007 to July, 2013. We excluded patients admitted for a primary psychiatric disorder. Medication exposures of interest, defined by pharmacy charges, included benzodiazepines, non-benzodiazepine benzodiazepine receptor agonists, trazodone, atypical antipsychotics, and diphenhydramine. In-hospital falls were ascertained from an online patient safety reporting system.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Among the 225,498 hospitalizations (median age = 57 years; 57.9% female) in our cohort, 84,911 (37.7%) had exposure to at least one of the five medication classes of interest; benzodiazepines were the most commonly used (23.5%), followed by diphenhydramine (8.3%), trazodone (6.6%), benzodiazepine receptor agonists (6.4%), and atypical antipsychotics (6.3%). A fall occurred in 2,427 hospitalizations (1.1%). The rate of falls per 1,000 hospital days was greater among hospitalizations with exposure to each of the medications of interest, compared to unexposed: 3.6 versus 1.7 for benzodiazepines (adjusted hazard ratio [aHR] 1.8, 95%CI 1.6–1.9); 5.4 versus 1.8 for atypical antipsychotics (aHR 1.6, 95%CI 1.4–1.8); 3.0 versus 2.0 for benzodiazepine receptor agonists (aHR 1.5, 95%CI 1.3–1.8); 3.3 versus 2.0 for trazodone (aHR 1.2, 95%CI 1.1–1.5); and 2.5 versus 2.0 for diphenhydramine (aHR 1.2, 95%CI 1.03–1.5).</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>In this large cohort of hospitalizations at an academic medical center, we found an association between each of the sedating medications examined and in-hospital falls. Benzodiazepines, benzodiazepine receptor agonists, and atypical antipsychotics had the strongest associations.</jats:p> </jats:sec>

収録刊行物

  • Sleep

    Sleep 44 (9), zsab064-, 2021-03-12

    Oxford University Press (OUP)

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ